Colchicine
1.5 mg at baseline then, 0.5 mg PO BID for 10 days.
Placebo
COVID-19 severe or critically
excluded patients : - treated with antimalarial drugs, azithromycin, convalescent plasma, remdesivir, tocilizumab, or baricitinib- subjects over 70 years old,
triple blind
Mexico
After the second pre-specified interim analysis, the committee informed the research group that although the treatment was safe, itwas inefective to prevent the development of the primary outcome and we decided to suspend the trial.